Pharmafile Logo
Pharmafocus logo
Advanced Search

EP0042 receives Orphan Drug Designation from the US Food and Drug Administration

March 14, 2023
Business Services

 Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …

News
Press release

Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

March 14, 2023
Business Services

Aarhus, Denmark March 14th, 2023: Teitur Trophics (“Teitur”), a biotech company dedicated to developing new treatments for patients suffering from …

News
Press release

Newron announces 2022 financial results and provides outlook for 2023

March 14, 2023
Business Services

Milan, Italy, March 14, 2023, 7 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …

News
Press release

Cell and Gene Therapy Catapult opens new Process Analytical Technologies laboratory

March 14, 2023
Business Services

London, 14 March 2023: The Cell and Gene Therapy Catapult (CGT Catapult) today announces the opening of a new laboratory …

News
Press release

US bill pushes Medicare and Medicaid categories for prescription digital therapeutics

March 14, 2023
Medical Communications

Both the US House of Representatives and Senate are considering a bill which would encourage the adoption of prescription digital …

News

GSK shares positive results from meningococcal disease vaccine trial

March 14, 2023
Research and Development

GSK has announced positive results from its vaccine candidate trial for meningococcal, which is a significant cause of meningitis and …

News

Occlutech launches FROST-HF study of heart failure device

March 14, 2023
Research and Development

Occlutech has announced that it has recruited its first patient in the FROST-HF study, which aims to investigate the company’s …

News

Pfizer signs $43bn deal to buy Seagen

March 14, 2023
Sales and Marketing

Pharma giant Pfizer has signed a definitive merger agreement valued at $43bn to buy biotech firm Seagen.   US-based Seagen …

News

Scottish patients with the most aggressive form of viral hepatitis become first in UK to be offered routine NHS access to Hepcludex® (bulevirtide)

March 14, 2023
Business Services

Monday 13 March 2023, London, UK – Gilead Sciences Ltd today announced that the Scottish Medicines Consortium (SMC) has become …

News
Press release

Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301

March 13, 2023
Business Services

KANSAS CITY, KANSAS and PRINCETON, NEW JERSEY – March 13, 2023 – Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing …

News
Press release

BRITISH LAND AND AUSTRALIANSUPER ANNOUNCE LIFE SCIENCES AMBITION AT CANADA WATER

March 13, 2023
Business Services

13 March 2023

News
Press release

Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy

March 13, 2023
Business Services

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced positive topline results from the global, randomized, double-blind, placebo-controlled …

News
Press release

Richard Stedman rejoins ACG as the CEO of Engineering Division

March 13, 2023
Business Services

ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce that …

Appointment

Sanofi to acquire Provention Bio in $2.9bn deal

March 13, 2023
Sales and Marketing

Sanofi has agreed to acquire Provention Bio as part of a $2.9bn deal that aims to improve the company’s portfolio …

News

Gilead Sciences wins $175m in ongoing HIV fraud case

March 13, 2023
Sales and Marketing

Gilead Sciences, a research-based biopharmaceutical company, has won again in the lawsuit levelled against clinics, prescribers, medical labs and pharmacies …

News

Nasal spray that relieves migraines in minutes approved by FDA

March 13, 2023
Medical Communications

Pfizer is planning to launch a fast-acting nasal spray that can relieve pain from migraines in as little as 15 …

News

Horizon Therapeutics announces real-world treatment results for Dysthyroid Optic Neuropathy drug

March 13, 2023
Medical Communications

Biopharma company Horizon Therapeutics has announced real-world treatment results for its Thyroid Eye Disease (TED) drug in patients with Dysthyroid …

News

Biotech centre focusing on gene therapies opens in Bristol, UK

March 10, 2023
Medical Communications

A new state-of-the-art facility named the Clinical Biotechnology Centre (CBC) is opening in Bristol, UK. It cost approximately £10m to …

News

FDA makes unusual ‘misinformation’ comment on Lucira’s EUA for COVID-19 and flu test

March 10, 2023
Sales and Marketing

The FDA has made a rare comment about what happened at Lucira Health’s Emergency Use Authorization (EUA) filing for its …

News

Acadia Pharmaceuticals awaits FDA decision for first-of-its-kind Rett syndrome drug

March 10, 2023
Research and Development

Acadia Pharmaceuticals is aiming to follow in the footsteps of Reata Pharmaceuticals, who won approval for its novel drug to …

News
The Gateway to Local Adoption Series

Latest content

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026